COMP <GO>
SCI vs PG // REVENUE GROWTH (YOY)
Service Corporation International (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: SCI 5
— PG 10
▲ REVENUE GROWTH (YOY) LEADER: SCI
LAST: $76.37 (+1.60%) • MKT CAP: $10.27B
revenue-growth
2.90%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
revenue-growth
0.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCI VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SCI | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.50% | 51.20% | -24.70 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 25.40% | -13.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 16.2x | -3.00 | SCI | /valuation <GO> |
| Free Cash Flow Yield | 7.29% | 3.77% | +3.52 | SCI | /fcf-yield <GO> |
| Operating Margin | 22.70% | 24.30% | -1.60 | PG | /operating-margins <GO> |
| Net Profit Margin | 12.60% | 19.00% | -6.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 2.90% | 0.30% | +2.60 | SCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.79% | 2.65% | -0.86 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.11 | 5.59 | -4.48 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.50% | +0.60 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.4 | 62.7 | -23.27 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.87 | +0.20 | SCI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.6x | 21.7x | -4.10 | SCI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.27B | $372.21B | -$361.94B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SCI REV | PG REV | SCI GROSS % | PG GROSS % | SCI FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.31B | $84.28B | 26.5% | 51.2% | $748.9M | $14.04B |
| FY 2024 | $4.19B | $84.04B | 26.1% | 51.4% | $756.5M | $16.52B |
| FY 2023 | $4.10B | $82.01B | 44.0% | 44.0% | $684.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCI // BETA 1.07
PG // BETA 0.87